首页 > 最新文献

Colorectal Disease最新文献

英文 中文
Patient characteristics, antibiotic use, and in-hospital outcomes in patients with ischaemic colitis: A nationwide retrospective cohort study. 缺血性结肠炎患者的患者特征、抗生素使用和住院结果:一项全国性回顾性队列研究
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70385
Yasuhiro Kano, Yuya Kimura, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga

Aim: To describe patient characteristics, management and in-hospital outcomes of ischaemic colitis, and to compare the rates of surgery and in-hospital death between patients who did and did not receive antibiotics.

Method: We retrospectively identified hospital admissions for ischaemic colitis between April 2016 and March 2023 from the Diagnosis Procedure Combination inpatient database in Japan. We described the overall patient characteristics, management practices and outcomes, which were stratified by antibiotic use. The primary outcome was a composite of receipt of surgery and in-hospital mortality. We examined the association between antibiotic use within the first 2 days of admission and the primary outcome occurring on or after day 3 of hospitalization using multivariable logistic regression analyses.

Results: Among 111,750 eligible cases, 36.2% received antibiotics within the first 2 days of admission. Of them, 0.9% underwent surgery and 1.3% died during hospitalization. The primary outcome occurred in 2.1% of cases in the overall cohort (≤2 days: 0.6%; ≥3 days: 1.5%) and in 1.0% of cases who did not receive (≤2 days: 0.2%; ≥3 days: 0.8%) and 4.2% of cases who received antibiotics (≤2 days: 1.5%; ≥3 days: 2.7%). After covariate adjustment, antibiotic use was associated with higher odds of the primary composite outcome (adjusted odds ratio 1.98, 95% confidence interval: 1.77-2.21).

Conclusion: The surgical rate and in-hospital mortality in ischaemic colitis were lower than previously reported. Antibiotic use was associated with higher odds of surgery and in-hospital mortality; however, this finding should be interpreted cautiously, given potential unmeasured confounding.

目的:描述缺血性结肠炎的患者特征、治疗和住院结果,并比较接受和未接受抗生素治疗的患者的手术率和住院死亡率。方法:我们回顾性地从日本诊断程序组合住院患者数据库中确定2016年4月至2023年3月期间的缺血性结肠炎住院患者。我们描述了患者的总体特征、管理实践和结果,并根据抗生素的使用进行了分层。主要结局是接受手术和住院死亡率的综合结果。我们使用多变量logistic回归分析检查了入院前2天内抗生素使用与住院第3天或之后发生的主要结局之间的关系。结果:在111,750例符合条件的病例中,36.2%的患者在入院前2天内使用了抗生素。其中0.9%接受手术治疗,1.3%在住院期间死亡。在整个队列中,2.1%的病例(≤2天:0.6%;≥3天:1.5%)、1.0%的未接受抗生素治疗的病例(≤2天:0.2%;≥3天:0.8%)和4.2%接受抗生素治疗的病例(≤2天:1.5%;≥3天:2.7%)出现了主要结局。协变量调整后,抗生素的使用与主要综合结局的较高几率相关(调整后的优势比为1.98,95%可信区间为1.77-2.21)。结论:缺血性结肠炎的手术率和住院死亡率低于文献报道。抗生素的使用与更高的手术几率和住院死亡率相关;然而,考虑到潜在的未测量的混杂因素,这一发现应谨慎解释。
{"title":"Patient characteristics, antibiotic use, and in-hospital outcomes in patients with ischaemic colitis: A nationwide retrospective cohort study.","authors":"Yasuhiro Kano, Yuya Kimura, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga","doi":"10.1111/codi.70385","DOIUrl":"https://doi.org/10.1111/codi.70385","url":null,"abstract":"<p><strong>Aim: </strong>To describe patient characteristics, management and in-hospital outcomes of ischaemic colitis, and to compare the rates of surgery and in-hospital death between patients who did and did not receive antibiotics.</p><p><strong>Method: </strong>We retrospectively identified hospital admissions for ischaemic colitis between April 2016 and March 2023 from the Diagnosis Procedure Combination inpatient database in Japan. We described the overall patient characteristics, management practices and outcomes, which were stratified by antibiotic use. The primary outcome was a composite of receipt of surgery and in-hospital mortality. We examined the association between antibiotic use within the first 2 days of admission and the primary outcome occurring on or after day 3 of hospitalization using multivariable logistic regression analyses.</p><p><strong>Results: </strong>Among 111,750 eligible cases, 36.2% received antibiotics within the first 2 days of admission. Of them, 0.9% underwent surgery and 1.3% died during hospitalization. The primary outcome occurred in 2.1% of cases in the overall cohort (≤2 days: 0.6%; ≥3 days: 1.5%) and in 1.0% of cases who did not receive (≤2 days: 0.2%; ≥3 days: 0.8%) and 4.2% of cases who received antibiotics (≤2 days: 1.5%; ≥3 days: 2.7%). After covariate adjustment, antibiotic use was associated with higher odds of the primary composite outcome (adjusted odds ratio 1.98, 95% confidence interval: 1.77-2.21).</p><p><strong>Conclusion: </strong>The surgical rate and in-hospital mortality in ischaemic colitis were lower than previously reported. Antibiotic use was associated with higher odds of surgery and in-hospital mortality; however, this finding should be interpreted cautiously, given potential unmeasured confounding.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70385"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facilitating endorobotic submucosal dissection (ERSD) in transanal single-port surgery: A comparative analysis of two ports-A video vignette. 在经肛门单孔手术中促进内生机器人粘膜下剥离(ERSD):两个孔的比较分析-视频片段。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70400
Ece Erenler, Metincan Erkaya, Mustafa Oruc, Salih Nafiz Karahan, Emre Gorgun
{"title":"Facilitating endorobotic submucosal dissection (ERSD) in transanal single-port surgery: A comparative analysis of two ports-A video vignette.","authors":"Ece Erenler, Metincan Erkaya, Mustafa Oruc, Salih Nafiz Karahan, Emre Gorgun","doi":"10.1111/codi.70400","DOIUrl":"https://doi.org/10.1111/codi.70400","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70400"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146149357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological considerations regarding long-term performance and interpretation of faecal immunochemical testing. 关于粪便免疫化学检测的长期性能和解释的方法学考虑。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70386
Ting Chen
{"title":"Methodological considerations regarding long-term performance and interpretation of faecal immunochemical testing.","authors":"Ting Chen","doi":"10.1111/codi.70386","DOIUrl":"10.1111/codi.70386","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70386"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Five-year recurrence and postoperative complications after laparoscopic complete Mesocolic excision: A population-based, multicentred study. 腹腔镜完整肠系膜切除术后5年复发和术后并发症:一项基于人群的多中心研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70380
Tora Haug, Jan Brink Valentin, Mai-Britt Worm Ørntoft, Lene Hjerrild Iversen, Søren Paaske Johnsen, Robin Kennedy, Danilo Miskovic, Anders Husted Madsen

Background: The oncological benefits of Laparoscopic Complete Mesocolic Excision (LCME) over conventional surgery are often challenged by single-centre designs, small cohorts or short and incomplete follow-up. This study aimed to examine the difference in recurrence risk 5 years after surgery and 30-day postoperative complications before and after a population-based, multicentre LCME implementation.

Method: LCME was implemented in the Central Denmark Region, Denmark following a training programme in 2017 for all colon cancer surgeons. Colon cancer patients from before (2015-2016, PRE-group) and after the implementation (2018-2019, POST-group) were identified through the Danish Colorectal Cancer Group Database. Recurrence 5 years after surgery was ascertained through national registers using a validated algorithm. The Aalen-Johansen estimator for competing risk was used to calculate cumulative incidence of recurrence.

Results: A total of 1919 patients (PRE, n = 1024; POST, n = 895) underwent curative-intended surgery in the study period. The 5-year cumulative incidence of recurrence was 16.1% (95% CI: 13.8, 18.4) in the PRE group and 12.5% (95% CI: 10.2, 14.9) in the POST group, with a significant absolute risk difference of 3.6% (95% CI: 0.3, 6.9). Furthermore, a significantly lower hazard rate of recurrence was observed in stage II patients after the LCME implementation, with a hazard rate ratio of 0.42 (95% Cl: 0.24, 0.72). Risk of severe postoperative complications was also significantly lower in the POST, compared to the PRE group.

Conclusion: LCME implementation was associated with a significantly lower risk of recurrence and lower rate of severe postoperative complications. This study indicates that multicentre LCME implementation may improve clinical outcomes without compromising patient safety.

背景:腹腔镜完整肠系膜切除术(LCME)相对于传统手术的肿瘤学益处经常受到单中心设计、小队列或短且不完整随访的挑战。本研究旨在研究以人群为基础的多中心LCME实施前后术后5年复发风险和术后30天并发症的差异。方法:LCME在2017年对所有结肠癌外科医生进行培训后在丹麦中部地区实施。通过丹麦结直肠癌组数据库确定实施前(2015-2016,pre -2016组)和实施后(2018-2019,post组)的结肠癌患者。术后5年复发率通过国家登记系统确定。竞争风险的aallen - johansen估计用于计算累积复发率。结果:在研究期间,共有1919例患者(PRE, n = 1024; POST, n = 895)接受了治愈性手术。PRE组5年累积复发率为16.1% (95% CI: 13.8, 18.4), POST组5年累积复发率为12.5% (95% CI: 10.2, 14.9),绝对风险差异为3.6% (95% CI: 0.3, 6.9)。此外,LCME实施后II期患者的危险复发率显著降低,危险率比为0.42 (95% Cl: 0.24, 0.72)。与PRE组相比,POST组发生严重术后并发症的风险也显著降低。结论:LCME的实施显著降低了复发风险和术后严重并发症的发生率。本研究表明,多中心LCME的实施可以在不影响患者安全的情况下改善临床结果。
{"title":"Five-year recurrence and postoperative complications after laparoscopic complete Mesocolic excision: A population-based, multicentred study.","authors":"Tora Haug, Jan Brink Valentin, Mai-Britt Worm Ørntoft, Lene Hjerrild Iversen, Søren Paaske Johnsen, Robin Kennedy, Danilo Miskovic, Anders Husted Madsen","doi":"10.1111/codi.70380","DOIUrl":"https://doi.org/10.1111/codi.70380","url":null,"abstract":"<p><strong>Background: </strong>The oncological benefits of Laparoscopic Complete Mesocolic Excision (LCME) over conventional surgery are often challenged by single-centre designs, small cohorts or short and incomplete follow-up. This study aimed to examine the difference in recurrence risk 5 years after surgery and 30-day postoperative complications before and after a population-based, multicentre LCME implementation.</p><p><strong>Method: </strong>LCME was implemented in the Central Denmark Region, Denmark following a training programme in 2017 for all colon cancer surgeons. Colon cancer patients from before (2015-2016, PRE-group) and after the implementation (2018-2019, POST-group) were identified through the Danish Colorectal Cancer Group Database. Recurrence 5 years after surgery was ascertained through national registers using a validated algorithm. The Aalen-Johansen estimator for competing risk was used to calculate cumulative incidence of recurrence.</p><p><strong>Results: </strong>A total of 1919 patients (PRE, n = 1024; POST, n = 895) underwent curative-intended surgery in the study period. The 5-year cumulative incidence of recurrence was 16.1% (95% CI: 13.8, 18.4) in the PRE group and 12.5% (95% CI: 10.2, 14.9) in the POST group, with a significant absolute risk difference of 3.6% (95% CI: 0.3, 6.9). Furthermore, a significantly lower hazard rate of recurrence was observed in stage II patients after the LCME implementation, with a hazard rate ratio of 0.42 (95% Cl: 0.24, 0.72). Risk of severe postoperative complications was also significantly lower in the POST, compared to the PRE group.</p><p><strong>Conclusion: </strong>LCME implementation was associated with a significantly lower risk of recurrence and lower rate of severe postoperative complications. This study indicates that multicentre LCME implementation may improve clinical outcomes without compromising patient safety.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70380"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rectal cancer following radiotherapy for prostate cancer: A propensity-matched analysis. 前列腺癌放疗后直肠癌:倾向匹配分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70365
M Goldenshluger, M A Abbas, M Belkovsky, A Alipouriani, K Erozkan, G Alon, M A Valente, S R Steele, S D Holubar, D Liska, E Gorgun
<p><strong>Aim: </strong>Patients who have previously received radiation therapy for primary prostate cancer (PPC) face an elevated risk of developing secondary rectal cancer (SRC). However, the clinical presentation, surgical outcomes, and oncological results of SRC in this context remain poorly characterized. This study aims to compare the clinical and pathological features, as well as treatment outcomes, of patients with primary rectal cancer (PRC) and those with SRC following radiation for prostate cancer.</p><p><strong>Methods: </strong>Retrospective cohort study using univariate and propensity-matched analyses. Data extracted from electronic medical records at a single tertiary institution [2001-2021]. Male patients with rectal cancer (RC) who underwent oncological resection with or without a prior history of prostate cancer radiation. Patients with a <3-year interval between radiotherapy and RC diagnosis were excluded. The main outcome measures were pathological analysis, postoperative complications and overall survival.</p><p><strong>Results: </strong>Out of 1,755 patients with RC, 50 cases (2.9%) had SRC. Forty-three out of the 50 patients were included in the analysis. The median time from radiotherapy to SRC diagnosis was 8 ± 4 years (IQR). Patients with SRC were older, with a mean age of 73.7 ± 8.5 versus 61.1 ± 13 years in the control group (p < 0.001), and a higher American Society of Anaesthesiologists (ASA) score (p = 0.006). Most SRCs were distal with a median distance from the anal verge of 4.25 cm (IQR 9.5 cm). Only seven patients (16.3%) in the SRC group received neoadjuvant radiation therapy versus 764 (44.8%) of PRC (p = 0.001). SRC patients required more extensive surgical interventions, including abdominoperineal resection (46.5% vs. 29.9%), pelvic exenteration (4.7% vs. 0.4%), and fewer sphincter-preserving procedures, including low anterior resection (48.8% vs. 68.2%) and transanal resection (0% vs. 1.5%) (p = 0.02). Propensity score matching with a 1:2 ratio matching for age, body mass index (BMI), ASA score, type of surgery, and pathological staging revealed no differences between the groups regarding tumour differentiation, staging, or postoperative complications. Survival analysis at 6 years showed no significant difference in overall survival between the SRC (53.2%, 95% CI: 35%-71%) and PRC (50.3%, 95% CI: 36%-64%) groups (p = 0.61).</p><p><strong>Limitations: </strong>Retrospective design and reliance on electronic medical records from a single institution.</p><p><strong>Conclusion: </strong>Patients with PPC developed SRC up to 10 years after radiation therapy. Patients with SRC were typically older with more comorbidities. Fewer patients with SRC underwent neoadjuvant therapy, and as a group, required more extensive surgeries with a lower rate of sphincter preservation compared to patients with PRC. Despite these differences, patients with SRC had similar pathological outcomes and overall survival compared to pat
目的:先前接受过原发性前列腺癌(PPC)放射治疗的患者患继发性直肠癌(SRC)的风险升高。然而,在这种情况下,SRC的临床表现、手术结果和肿瘤结果仍然缺乏特征。本研究旨在比较原发性直肠癌(PRC)患者和SRC患者在前列腺癌放疗后的临床和病理特征以及治疗结果。方法:回顾性队列研究,采用单变量分析和倾向匹配分析。数据摘自单一高等教育机构的电子病历[2001-2021]。有或没有前列腺癌放疗史的男性直肠癌(RC)患者行肿瘤切除术。结果:在1755例RC患者中,50例(2.9%)发生了SRC。50名患者中的43名被纳入分析。从放疗到SRC诊断的中位时间为8±4年(IQR)。SRC患者年龄较大,平均年龄为73.7±8.5岁,对照组为61.1±13岁(p局限性:回顾性设计和对单一机构电子病历的依赖)。结论:PPC患者在放疗后10年出现SRC。SRC患者通常年龄较大,合并症较多。与PRC患者相比,接受新辅助治疗的SRC患者较少,并且作为一个群体,与PRC患者相比,需要更广泛的手术,括约肌保留率更低。尽管存在这些差异,与PRC患者相比,SRC患者具有相似的病理结果和总生存期。
{"title":"Rectal cancer following radiotherapy for prostate cancer: A propensity-matched analysis.","authors":"M Goldenshluger, M A Abbas, M Belkovsky, A Alipouriani, K Erozkan, G Alon, M A Valente, S R Steele, S D Holubar, D Liska, E Gorgun","doi":"10.1111/codi.70365","DOIUrl":"10.1111/codi.70365","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;Patients who have previously received radiation therapy for primary prostate cancer (PPC) face an elevated risk of developing secondary rectal cancer (SRC). However, the clinical presentation, surgical outcomes, and oncological results of SRC in this context remain poorly characterized. This study aims to compare the clinical and pathological features, as well as treatment outcomes, of patients with primary rectal cancer (PRC) and those with SRC following radiation for prostate cancer.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Retrospective cohort study using univariate and propensity-matched analyses. Data extracted from electronic medical records at a single tertiary institution [2001-2021]. Male patients with rectal cancer (RC) who underwent oncological resection with or without a prior history of prostate cancer radiation. Patients with a &lt;3-year interval between radiotherapy and RC diagnosis were excluded. The main outcome measures were pathological analysis, postoperative complications and overall survival.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Out of 1,755 patients with RC, 50 cases (2.9%) had SRC. Forty-three out of the 50 patients were included in the analysis. The median time from radiotherapy to SRC diagnosis was 8 ± 4 years (IQR). Patients with SRC were older, with a mean age of 73.7 ± 8.5 versus 61.1 ± 13 years in the control group (p &lt; 0.001), and a higher American Society of Anaesthesiologists (ASA) score (p = 0.006). Most SRCs were distal with a median distance from the anal verge of 4.25 cm (IQR 9.5 cm). Only seven patients (16.3%) in the SRC group received neoadjuvant radiation therapy versus 764 (44.8%) of PRC (p = 0.001). SRC patients required more extensive surgical interventions, including abdominoperineal resection (46.5% vs. 29.9%), pelvic exenteration (4.7% vs. 0.4%), and fewer sphincter-preserving procedures, including low anterior resection (48.8% vs. 68.2%) and transanal resection (0% vs. 1.5%) (p = 0.02). Propensity score matching with a 1:2 ratio matching for age, body mass index (BMI), ASA score, type of surgery, and pathological staging revealed no differences between the groups regarding tumour differentiation, staging, or postoperative complications. Survival analysis at 6 years showed no significant difference in overall survival between the SRC (53.2%, 95% CI: 35%-71%) and PRC (50.3%, 95% CI: 36%-64%) groups (p = 0.61).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;Retrospective design and reliance on electronic medical records from a single institution.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Patients with PPC developed SRC up to 10 years after radiation therapy. Patients with SRC were typically older with more comorbidities. Fewer patients with SRC underwent neoadjuvant therapy, and as a group, required more extensive surgeries with a lower rate of sphincter preservation compared to patients with PRC. Despite these differences, patients with SRC had similar pathological outcomes and overall survival compared to pat","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70365"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12852529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assurance of rectal side arterial and venous perfusion with indocyanine green fluorescence angiography during anterior resection-A Video Vignette. 用吲哚菁绿荧光血管造影检查直肠侧动脉和静脉在前切除术中的灌注-视频片段。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70394
Ronan A Cahill
{"title":"Assurance of rectal side arterial and venous perfusion with indocyanine green fluorescence angiography during anterior resection-A Video Vignette.","authors":"Ronan A Cahill","doi":"10.1111/codi.70394","DOIUrl":"10.1111/codi.70394","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70394"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146117889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translating rectopexy practice variability into precision care innovative directions. 将直肠矫正术实践的可变性转化为精准护理的创新方向。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70391
Zejun Song, Yiqi Guo
{"title":"Translating rectopexy practice variability into precision care innovative directions.","authors":"Zejun Song, Yiqi Guo","doi":"10.1111/codi.70391","DOIUrl":"10.1111/codi.70391","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70391"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Topical versus oral metronidazole for post-haemorrhoidectomy pain: A systematic review and meta-analysis of randomized controlled trials. 致编辑的信:局部与口服甲硝唑治疗痔切除术后疼痛:随机对照试验的系统回顾和荟萃分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70403
Yuting Shi, Saiya Shi, Yixin Lan
{"title":"Letter to the Editor: Topical versus oral metronidazole for post-haemorrhoidectomy pain: A systematic review and meta-analysis of randomized controlled trials.","authors":"Yuting Shi, Saiya Shi, Yixin Lan","doi":"10.1111/codi.70403","DOIUrl":"https://doi.org/10.1111/codi.70403","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70403"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146149387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TAMIS procedure for a recurrent rectal lesion at anastomotic site-A video vignette. 吻合口复发性直肠病变的TAMIS手术-视频片段。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70389
Ejaz Ahmed Latif, Ali Toffaha, Ammar Aleter, Amjad Parvaiz, Mohamed Abu Nada, Mohamed Kurer
{"title":"TAMIS procedure for a recurrent rectal lesion at anastomotic site-A video vignette.","authors":"Ejaz Ahmed Latif, Ali Toffaha, Ammar Aleter, Amjad Parvaiz, Mohamed Abu Nada, Mohamed Kurer","doi":"10.1111/codi.70389","DOIUrl":"10.1111/codi.70389","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70389"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiences of LGB patients undergoing colorectal cancer surgery: A focus on sexuality. 结直肠癌手术中LGB患者的经验:对性的关注。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.1111/codi.70375
Anna Provoost, Louis Onghena, Khushi Jeswani, Yves van Nieuwenhove, Eva Pape, Gabrielle H van Ramshorst

Purpose: This study aimed to delineate the existing knowledge regarding the impact of colorectal cancer surgery on the sexuality of LGB patients, highlighting the need for culturally competent care tailored to their unique needs.

Methods: A comprehensive search was conducted from October 2024 onwards across PubMed, Embase, CINAHL, Google Scholar, Web of Science, Scopus, PsychINFO, Cochrane Library, and Joanna Briggs Institute using the MeSH terms 'sexual and gender minorities', 'colorectal surgery', 'colorectal neoplasms' and 'sexuality'. Inclusion criteria required LGB patients over 18 years, at least 50% of the sample diagnosed with colorectal cancer and treated operatively. All studies were critically appraised.

Results: Six studies from the UK and the US were included. Sample size ranged from 1 to 480. Participants identifying as LGB ranged from 26.4 to 100%. Key findings revealed LGB patients experience similar physical consequences to heterosexual patients (erectile and ejaculatory dysfunction, dyspareunia, vaginal dryness), but implications might differ, e.g., regarding anal intercourse. A lower mental quality of life was reported, including body image issues related to stomas. Relationship challenges and intimacy issues were highlighted. The cultural competence of healthcare providers has a significant influence on patient experiences, highlighting a gap in inclusive care. Critical appraisal revealed both methodological strengths and weaknesses.

Conclusion: This review highlighted the sexual health challenges of LGB patients after colorectal cancer surgery, with issues like sexual function and mental wellbeing often being underreported. Cultural competence training for healthcare providers and integrating patients' partners into cancer care are crucial for a holistic approach.

目的:本研究旨在描述关于结直肠癌手术对LGB患者性取向影响的现有知识,强调需要针对他们的独特需求量身定制具有文化能力的护理。方法:从2024年10月起在PubMed、Embase、CINAHL、b谷歌Scholar、Web of Science、Scopus、PsychINFO、Cochrane Library和Joanna Briggs Institute进行全面检索,使用MeSH术语“性和性别少数群体”、“结直肠外科”、“结直肠肿瘤”和“性”。纳入标准要求18岁以上的LGB患者,至少50%的样本被诊断为结直肠癌并接受手术治疗。所有的研究都经过严格的评价。结果:纳入了来自英国和美国的6项研究。样本量从1到480。认同为LGB的参与者从26.4%到100%不等。主要研究结果显示,LGB患者与异性恋患者经历相似的生理后果(勃起和射精功能障碍、性交困难、阴道干燥),但含义可能有所不同,例如,在肛交方面。据报道,精神生活质量较低,包括与气孔有关的身体形象问题。强调了关系挑战和亲密问题。医疗保健提供者的文化能力对患者体验有重大影响,突出了包容性护理的差距。批判性评价揭示了方法论的优点和缺点。结论:本综述强调了结直肠癌手术后LGB患者的性健康挑战,性功能和心理健康等问题往往被低估。对医疗保健提供者进行文化能力培训,并将患者的合作伙伴纳入癌症护理中,这对整体方法至关重要。
{"title":"Experiences of LGB patients undergoing colorectal cancer surgery: A focus on sexuality.","authors":"Anna Provoost, Louis Onghena, Khushi Jeswani, Yves van Nieuwenhove, Eva Pape, Gabrielle H van Ramshorst","doi":"10.1111/codi.70375","DOIUrl":"https://doi.org/10.1111/codi.70375","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to delineate the existing knowledge regarding the impact of colorectal cancer surgery on the sexuality of LGB patients, highlighting the need for culturally competent care tailored to their unique needs.</p><p><strong>Methods: </strong>A comprehensive search was conducted from October 2024 onwards across PubMed, Embase, CINAHL, Google Scholar, Web of Science, Scopus, PsychINFO, Cochrane Library, and Joanna Briggs Institute using the MeSH terms 'sexual and gender minorities', 'colorectal surgery', 'colorectal neoplasms' and 'sexuality'. Inclusion criteria required LGB patients over 18 years, at least 50% of the sample diagnosed with colorectal cancer and treated operatively. All studies were critically appraised.</p><p><strong>Results: </strong>Six studies from the UK and the US were included. Sample size ranged from 1 to 480. Participants identifying as LGB ranged from 26.4 to 100%. Key findings revealed LGB patients experience similar physical consequences to heterosexual patients (erectile and ejaculatory dysfunction, dyspareunia, vaginal dryness), but implications might differ, e.g., regarding anal intercourse. A lower mental quality of life was reported, including body image issues related to stomas. Relationship challenges and intimacy issues were highlighted. The cultural competence of healthcare providers has a significant influence on patient experiences, highlighting a gap in inclusive care. Critical appraisal revealed both methodological strengths and weaknesses.</p><p><strong>Conclusion: </strong>This review highlighted the sexual health challenges of LGB patients after colorectal cancer surgery, with issues like sexual function and mental wellbeing often being underreported. Cultural competence training for healthcare providers and integrating patients' partners into cancer care are crucial for a holistic approach.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70375"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Colorectal Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1